http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2526203-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bb2eff32b894adcc76eab8bdc3d8485
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
filingDate 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f5b397cb860e81b431e78e0a2e78f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b86e761f12467a21c1c9ff9ad04b0fc
publicationDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2526203-C1
titleOfInvention Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows
abstract FIELD: veterinary medicine. n SUBSTANCE: method for production of anti-luteolytic blood - AlB is that luteolisate is administered subcutaneously to gelding twice with an interval of 14 days at a dose of 20 ml each, containing parts of the corpus luteum of pregnancy of cows, and after 14 days after the second administration the blood is taken from the jugular vein. The method of treatment and prevention of persistent corpus luteum, subinvolution of uterus and postpartum endometritis in cows comprises at the background of general therapy the use of anti-luteolytic blood that is administered subcutaneously in the neck region twice at a dose of 10 ml each with an interval of 6 days. n EFFECT: use of anti-luteolytic blood promotes the resorption of the corpus luteum of pregnancy and shortens the duration of postpartum involution of genitals that enables to prevent and reduce the time of treatment of ill cows with persistent corpus luteum, subinvolution of uterus and postpartum endometritis. n 2 cl
priorityDate 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2294752-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2538582-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500587

Total number of triples: 24.